Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | ATM | Q13315 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 10/20 | 0.41 |
| ▸ | CA2 | P00918 | 10/20 | 0.41 |
| ▸ | CA12 | O43570 | 2/20 | 0.40 |
| ▸ | CA9 | Q16790 | 2/20 | 0.40 |
| ▸ | CA4 | P22748 | 3/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | BCHE | P06276 | 1/20 | 0.34 |
| ▸ | ACHE | P22303 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7170464 | 1.00 | KMT2A (0.43) | KMT2AATMCA1CA2CA12 | |
| SCHEMBL443090 | 0.91 | KMT2A (0.41) | KMT2AATMCA1CA2CA12 | |
| SCHEMBL437799 | 0.91 | KMT2A (0.41) | KMT2AATMCA1CA2CA12 | |
| SCHEMBL6560864 | 0.89 | KMT2A (0.37) | KMT2AATMCA1CA2CA12 | |
| SCHEMBL437797 | 0.86 | KMT2A (0.38) | KMT2AATMCA1CA2CA12 | |
| SCHEMBL437798 | 0.86 | KMT2A (0.38) | KMT2AATMCA1CA2CA12 | |
| SCHEMBL443089 | 0.86 | KMT2A (0.38) | KMT2AATMCA1CA2CA12 | |
| SCHEMBL23831089 | 0.85 | CA1 (0.41) | KMT2AATMCA1CA2CA12 | |
| SCHEMBL29361887 | 0.85 | CA1 (0.41) | KMT2AATMCA1CA2CA12 | |
| SCHEMBL13814038 | 0.84 | KMT2A (0.44) | KMT2AATMCA1CA2CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12111313-B2 | Chelator-coated field effect transistor and devices and methods using same | Autonomous Medical Devices Inc. (US) | 2024-10-08 | — | — | US | claimed |
| CN-116296702-B | Dead-living dye capable of customizing detection channel based on mass spectrometry detection technology and preparation method and application thereof | 杭州普罗亭医学检验实验室有限公司 | 2023-12-29 | — | — | CN | claimed |
| CN-116296702-A | Dead-living dye capable of customizing detection channel based on mass spectrometry detection technology and preparation method and application thereof | 杭州普罗亭医学检验实验室有限公司 | 2023-06-23 | — | — | CN | claimed |
| US-20210293798-A1 | Chelator-Coated Field Effect Transistor and Devices and Methods Using Same | Autonomous Medical Devices Inc. (US) | 2021-09-23 | — | — | US | claimed |
| EP-3837541-A1 | CHELATOR-COATED FIELD EFFECT TRANSISTOR AND DEVICES AND METHODS USING SAME | Autonomous Medical Devices Incorporated (US) | 2021-06-23 | — | — | EP | claimed |
| WO-2020037078-A1 | CHELATOR-COATED FIELD EFFECT TRANSISTOR AND DEVICES AND METHODS USING SAME | Sensor-Kinesis Corporation (US) | 2020-02-20 | — | — | WO | claimed |
| US-12111313-B2 | Chelator-coated field effect transistor and devices and methods using same | Autonomous Medical Devices Inc. (US) | 2024-10-08 | — | — | US | disclosed |
| CN-116296702-B | Dead-living dye capable of customizing detection channel based on mass spectrometry detection technology and preparation method and application thereof | 杭州普罗亭医学检验实验室有限公司 | 2023-12-29 | — | — | CN | disclosed |
| CN-116296702-A | Dead-living dye capable of customizing detection channel based on mass spectrometry detection technology and preparation method and application thereof | 杭州普罗亭医学检验实验室有限公司 | 2023-06-23 | — | — | CN | disclosed |
| US-20210293798-A1 | Chelator-Coated Field Effect Transistor and Devices and Methods Using Same | Autonomous Medical Devices Inc. (US) | 2021-09-23 | — | — | US | disclosed |
| EP-3837541-A1 | CHELATOR-COATED FIELD EFFECT TRANSISTOR AND DEVICES AND METHODS USING SAME | Autonomous Medical Devices Incorporated (US) | 2021-06-23 | — | — | EP | disclosed |
| WO-2020037078-A1 | CHELATOR-COATED FIELD EFFECT TRANSISTOR AND DEVICES AND METHODS USING SAME | Sensor-Kinesis Corporation (US) | 2020-02-20 | — | — | WO | disclosed |
| EP-2561334-A1 | PRODUCTS AND METHODS FOR TISSUE PRESERVATION | Genvault Corporation (US) | 2013-02-27 | — | — | EP | disclosed |
| WO-2011130280-A1 | PRODUCTS AND METHODS FOR TISSUE PRESERVATION | GENVAULT CORPORATION (US) | 2011-10-20 | — | — | WO | disclosed |
| US-20110256530-A1 | PRODUCTS AND METHODS FOR TISSUE PRESERVATION | GENVAULT CORPORATION (US) | 2011-10-20 | — | — | US | disclosed |
| US-20040167330-A1 | Novel chelating agents and conjugates thereof, their synthesis and use as diagnois and therapeutic agents | THERAPHARM GMBH (CH) | 2004-08-26 | — | — | US | disclosed |
| EP-1406879-A1 | NOVEL CHELATING AGENTS AND CONJUGATES THEREOF, THEIR SYNTHESIS AND USE AS DIAGNOSTIC AND THERAPEUTIC AGENTS | Therpharm GmbH (CH) | 2004-04-14 | — | — | EP | disclosed |
| WO-2003008394-A1 | NOVEL CHELATING AGENTS AND CONJUGATES THEREOF, THEIR SYNTHESIS AND USE AS DIAGNOSTIC AND THERAPEUTIC AGENTS | THERAPHARM GMBH (CH) | 2003-01-30 | — | — | WO | disclosed |
| US-4917878-A | RADIOSCINTIGRAPHIC DETECTION; CHELATE COMPOUNDS | THOMAS JEFFERSON UNIVERSITY (US) | 1990-04-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040167330-A1 | Novel chelating agents and conjugates thereof, their synthesis and use as diagnois and therapeutic agents | PAICS, BPGM, PCNA | KMT2A 1331/4885ATM 3276/4885CA1 1254/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.